首页
订购/客服:400-666-5481

GLPG1837

    
10mM in DMSO

GLPG1837

源叶(MedMol)
T96354 一键复制产品信息
1654725-02-6
C16H20N4O3S
348.42
ABBV-9741H-​Pyrazole-​3-​carboxamide,N-​[3-​(aminocarbonyl)​-​4,​7-​dihydro-​5,​5,​7,​7-​tetramethyl-​5H-​thieno[2,​3-​c]​pyran-​2-​yl]​-
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
T96354-1ml促销
10mM in DMSO

¥720.00 ¥648.00

5 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CFTR 活化剂;CFTR Activators;;InformationGLPG1837 GLPG1837 (ABBV-974) is a novel CFTR potentiator with an EC50 value of 3 nM for F508del, showing enhanced efficacy on CFTR mutants harboring class III mutations compared to Ivacaftor.TargetsCFTR(F508del) ; CFTR(G551D) 3 nM(EC50); 339 nM(EC50)In vitroGLPG1837 has an attractive in vitro ADME profile, showing low Clint,unb in both microsomal and hepatocytes stability assays, good permeability, and no off-target inhibition of CYPs and the hERG channel.In vivoThe pharmacokinetic profile of GLPG1837 is attractive, showing a low Cl,unb and good F% in both rat and dog. The CL (L/h/kg) of GLPG1837 after intravenous injection of 1 mg/kg dose are 1.92 and 0.32 in rats and dogs, respectively. T1/2 is 1.84 h in rats while 3 h in dogs. After 5 mg/kg p.o, the oral availability of GLPG1837 in rat is 67%. In dogs, F%>100.
靶点: EC50: 3 nM (F508del CFTR), 339 nM (G551D CFTR)
参考文献: 1. Van der Plas SE, et al. Discovery of N-(3-Carbamoyl-5,5,7,7-tetramethyl-5,7-dihydro-4H-thieno[2,3-c]pyran-2-yl)-lH-pyrazole-5-carboxamide (GLPG1837), a Novel Potentiator Which Can Open Class III Mutant Cystic Fibrosis Transmembrane Conductance Regulator (
2. Yeh HI, et al. A common mechanism for CFTR potentiators. J Gen Physiol. 2017 Dec 4;149(12):1105-1118.
保存条件: -80℃(运输条件:冰袋低温运输)
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.87 ml 14.35 ml 28.701 ml
5 mM 0.574 ml 2.87 ml 5.74 ml
10 mM 0.287 ml 1.435 ml 2.87 ml
50 mM 0.057 ml 0.287 ml 0.574 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×